The tariff classification of IMMUNOCYT™ from Canada
Issued June 30, 2000 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3002.10.0090
Headings: 3002
Product description
The subject product, IMMUNOCYT™, is an in-vitro diagnostic test, in kit form, for the detection of bladder cancer. The kit consists of five (5) components (“reagents”), namely: a blocking solution, an antibody solution, a sample fixative, a positive control, and a negative control. The components are put up in a flip-open paperboard box. According to the package insert, “[I]mmunocyt™ is an immunocytofluorescent technique based on … a monoclonal antibody cocktail labeled with fluorescent markers. This monoclonal antibody cocktail consists of two antibodies which bind to a mucin glycoprotein, and one antibody specific to a glycosylated form of carcinoembryonic antigen (CEA). These two specific antigens are expressed in a selective fashion by the tumor cells in the bladder. The antibody solution is incubated with urinary cells collected by filtration and transferred to slides. The cells expressing tumor antigens are detected by epifluorescent microscopy.” In our opinion, the essential character of the kit is imparted by the antibody solution. Pursuant to Rule 3(b) of the General Rules of Interpretation, HTS, and the Explanatory Notes to heading 3822, HTS,
CBP rationale
the applicable subheading for the subject product will be 3002.10.0090, Harmonized Tariff Schedule of the United States (HTS), which provides for "[A]ntisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes: Other.
Full text
NY F88476 June 30, 2000 CLA-2-30:RR:NC:2:238 F88476 CATEGORY: Classification TARIFF NO.: 3002.10.0090 Mr. D.G. McKenny Norman G. Jensen, Inc. P.O. Box 1439 47 Caswell Avenue Derby Line, Vermont 05830 RE: The tariff classification of IMMUNOCYT™ from Canada Dear Mr. McKenny: In your letter dated June 13, 2000, on behalf of your client, DiagnoCure Inc., you requested a tariff classification ruling. The subject product, IMMUNOCYT™, is an in-vitro diagnostic test, in kit form, for the detection of bladder cancer. The kit consists of five (5) components (“reagents”), namely: a blocking solution, an antibody solution, a sample fixative, a positive control, and a negative control. The components are put up in a flip-open paperboard box. According to the package insert, “[I]mmunocyt™ is an immunocytofluorescent technique based on … a monoclonal antibody cocktail labeled with fluorescent markers. This monoclonal antibody cocktail consists of two antibodies which bind to a mucin glycoprotein, and one antibody specific to a glycosylated form of carcinoembryonic antigen (CEA). These two specific antigens are expressed in a selective fashion by the tumor cells in the bladder. The antibody solution is incubated with urinary cells collected by filtration and transferred to slides. The cells expressing tumor antigens are detected by epifluorescent microscopy.” In our opinion, the essential character of the kit is imparted by the antibody solution. Pursuant to Rule 3(b) of the General Rules of Interpretation, HTS, and the Explanatory Notes to heading 3822, HTS, the applicable subheading for the subject product will be 3002.10.0090, Harmonized Tariff Schedule of the United States (HTS), which provides for "[A]ntisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes: Other." The general rate of duty will be free. This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which is administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number 301-443-1544. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 212-637-7068. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Actinase AS (CAS-9001-92-7) from Japan
The tariff classification of the SureScreen 6 Drug Multi Test (Catalog# MLT 406), and the One-Step Cannabis (THC) Test, from the United Kingdom
COUNTRY OF ORIGIN MARKING OF IMPORTED PREGNANCY TESTS; ARTICLE 509
The tariff classification of heme-iron polypeptide (HIP) from Japan
The tariff classification of Precise One-Step Pregnancy Test and RapidVue 1-Step Pregnancy Test from Mexico
The tariff classification of Hyate:C (Antihemophilic Factor, Porcine), imported in vials, from the United Kingdom
The applicability of duty exemption, under subheading 9801.00.10, HTSUS, to monoclonal antibodies processed in Belgium
Request for tariff classification of the "Gluten HomeTest Kit"
The tariff classification of in-vitro immunoassay reagents, put up in plastic cassettes, and calibration reagent kits, from the United Kingdom
The tariff classification of Dynabeads anti-E.coli 0157 andDynabeads anti-Salmonella coated beads, from Norway
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →